Meet the Scientists
IHVR Faculty
Joe Aceto
Professor
IP issues
Alex Birk, Ph.D.
Principal Investigator
Dr. Birk was awarded his Doctorate of Philosophy in Pharmacology from Weill Graduate School of Medical Sciences College of Cornell University in New York where he also pursued his Postdoctoral training and held an Instructor position in Biochemistry and Pharmacology. In his position at IHVR, Dr. Birk is working on developing aminoglycoside-based antivirals against pathogenic Flaviviruses. Read Bio.
Songming Chen, Ph.D.
Asst Professor
Dr. Chen is currently working on Hepatitis B, HCV Proteomics, and array technology
Andrea Cuconati, Ph.D.
Project Leader, Drug Discovery
Dr. Cuconati leads the antiviral drug screening and discovery program
at the Institute for Hepatitis and Virus Research. He will also prepare
grant applications to the NIH and other funding sources to complement
this work. He joins the project from ViroPharma, Inc., where he contributed
to a successful effort to discover drugs against potential agents of bioterrorism. Read Bio.
Yanming Du, Ph.D.
Assistant Professor, Chemistry
William Kinney, Ph.D.
Professor of Chemistry
Dr. Kinney is investigating antiviral approaches based on improving the host’s resistance. He is also the Keystone Innovation Zone Coordinator at the Pennsylvania Biotechnology Center and an Entrepreneur. Read Bio
Fred Klaessig, Ph.D.
Professor, Medicinal Chemistry
Dr. Klaessig is currently with Pennsylvania Bio Nano Systems, a small firm focusing
on reference materials used in investigating chromatographic effects at the nanoscale. Read Bio
Hari Namboodiri
Ramila Philip, Ph.D.
Senior Scientist and Project Leader, Biomarker Discovery
Dr. Ramila Philip is an experienced immunologist specializing in use of
mass spectrometry for the study of MHC class I epitopes. She brings more
than 20 years of professional scientific experience to the Institute for
Hepatitis and Virus Research and will serve as manager of the science,
when Dr. Block is unavailable, and lead the mass spectrophotometry component
and the ELISA development of this project. Read Bio.
Xiangdong David Ren, M.D., Ph.D.
Principal Investigator
Early disease detection, DNA assays, Reniguard biotech co
Thomas Russell, Ph.D.
Professor
Russell Biotech Company
Kunwar Shailubhai, Ph.D., MBA
Principal Investigator
Dr.Kunwar Shailubhai is Senior Vice President, Drug Discovery, of Callisto Pharmaceuticals Inc. He previously served as a Senior Staff Fellow at the National Institutes of Health, and as an Assistant Professor at the University of Maryland. Read Bio.
Jim Thacker, Ph.D.
Professor
Lipopeptide therapeutics, Therimunex biotech co
Michael Xu, Ph.D.
Associate Professor, V.P. Investigator
Dr. Xu manages the medicinal chemistry efforts for the discovery of novel therapies for viral hepatitis at the Institute for Hepatitis and Virus Research. At the same time, Dr. Xu serves as President of Enantigen Therapeutics, Inc., a drug discovery & development company for viral hepatitis and other life threatening diseases at the Pennsylvania Biotechnology Center. He is also a co-founder of Pharmabridge, Inc. Read Bio
Adjunct Faculty
Jinhong Chang, M.D., Ph.D.
Research Assistant Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Discovery of antiviral drugs targeting host factors or enhancing innate immune response; regulation of viral replication by microRNA. Read Bio
Jeff Freedman
Haitao Guo, Ph.D.
Assistant Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Molecular pathway of HBV cccDNA formation and cccDNA regulation by viral and cellular factors; Development of in vitro assay systems for discovery of novel antiviral drugs. Read Bio
Ju-Tao Guo, M.D.
Associate Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Molecular pathogenesis of hepatitis and dengue virus infection, interferon mediated innate immunity and antiviral drug discovery. Read Bio
Pooja Jain, Ph.D.
Associate Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Dendritic cells in autoimmune and neuroinflammatory disease Read Bio
Zakar Khan, Ph.D.
Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Animal modeling of microbial infections and neuroinflammation Read Bio
Xuanyong Lu, Ph.D.
Assistant Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Cellular susceptibility to hepatitis B (HBV) infection; developing strategies to control cancer cell growth through silencing of overexpressed apoptosis inhibitors Read Bio
Bruce Marynoff, Ph.D.
Professor (Distinguished)
Drug discovery
Anand Mehta, D.Phil.
Associate Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Development of new hepatitis B (HBV) therapeutics; identification of early markers of liver cancer Read Bio
Scott Millhouse, Ph.D.
Research Assistant Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
The host-pathogen relationship and its importance to lytic and latent phases of the herpes virus life-cycle Read Bio
Brad Nefsky, Ph.D.
Assistant Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Pamela Norton, Ph.D.
Associate Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Development of novel antiviral drugs for use against hepatitis B virus (HBV) infection; host cell defenses against HBV infection Read Bio
Allen Reitz, Ph.D.
Distinguished Professor and Director, PA Center for Drug Discovery
Medicinal Chemistry
Patrick Romano, Ph.D.
Associate Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Early disease detection, glycobiology assays, molecular biology
Joe Salvino, Ph.D.
Associate Professor
Chemistry
Ysin-Hsui Su, Ph.D.
Associate Professor, Microbiology and Immunology,
Drexel Institute for Biotechnology and Virology Research
Understanding interactions between herpes simplex virus type 1 (HSV-1) and neurons during viral latency and reactivation; using nucleic acids in urine as diagnostic markers of cancer Read Bio
Sergey Ilyin, Ph.D.
Adjunct Faculty
Serigene Biotech
|
